CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821386754
- Phone
- 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 33 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-10 | Nandabalan Krishnan Director | Sale | −27,450 | $15.00 | $412K | 0 |
| 2022-11-10 | Nandabalan Krishnan Director | Option exercise · Stock Options | −27,450 | 446,550 | ||
| 2022-07-01 | MILLER MICHAEL PATRICK Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2022-05-19 | Bray June Director | Grant or award · Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2022-05-19 | MUELLER PETER Director | Grant or award · Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2022-05-19 | Votruba Michal Director | Grant or award · Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2022-05-19 | Votruba Michal Director | Other disposition · Stock Option (Right to Buy) | −17,000 | 0 | ||
| 2022-05-19 | Laumas Sandeep Director | Grant or award · Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2022-05-14 | Mehta Vimal CEO and President | Grant or award · Restricted Stock Units | +15,000 | 15,000 | ||
| 2022-05-14 | Steinhart Richard I Senior VP and CFO | Grant or award · Restricted Stock Units | +5,000 | 5,000 | ||
| 2022-05-14 | Rodriguez Javier See Remarks | Grant or award · Restricted Stock Units | +5,000 | 5,000 | ||
| 2022-03-14 | O'Neill Vincent Chief Medical Officer | Grant or award · Restricted Stock Units | +8,337 | 8,337 | ||
| 2022-03-14 | Rodriguez Javier See Remarks | Grant or award · Restricted Stock Units | +8,337 | 8,337 | ||
| 2022-03-14 | Rodriguez Javier See Remarks | Grant or award · Stock Option (Right to Buy) | +33,350 | 33,350 | ||
| 2022-03-14 | Mehta Vimal CEO and President | Grant or award · Restricted Stock Units | +41,750 | 41,750 | ||
| 2022-03-14 | Mehta Vimal CEO and President | Grant or award · Stock Option (Right to Buy) | +167,000 | 167,000 | ||
| 2022-03-14 | Steinhart Richard I Chief Financial Officer | Grant or award · Restricted Stock Units | +8,337 | 8,337 | ||
| 2022-03-14 | Steinhart Richard I Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +33,350 | 33,350 | ||
| 2022-03-14 | Yocca Frank Chief Scientific Officer | Grant or award · Restricted Stock Units | +8,337 | 8,337 | ||
| 2022-03-14 | Yocca Frank Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +33,350 | 33,350 |
Page 22 of 27 · 521 trades